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Abstract
YB-1, a multifunctional DNA- and RNA-binding nucleocytoplasmic protein, is involved in the majority of DNA- and mRNA-
dependent events in the cell. It consists of three structurally different domains: its central cold shock domain has the
structure of a b-barrel, while the flanking domains are predicted to be intrinsically disordered. Recently, we showed that YB-
1 is capable of forming elongated fibrils under high ionic strength conditions. Here we report that it is the cold shock
domain that is responsible for formation of YB-1 fibrils, while the terminal domains differentially modulate this process
depending on salt conditions. We demonstrate that YB-1 fibrils have amyloid-like features, including affinity for specific dyes
and a typical X-ray diffraction pattern, and that in contrast to most of amyloids, they disassemble under nearly physiological
conditions.
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Introduction
YB-1 is a multifunctional nucleocytoplasmic protein that
interacts with both RNA and DNA. YB-1 mediates mRNA
localization on tubulin [1,2] and actin [3] cytoskeletons. It can be
found in stress granules [4], P-bodies [5] and centrosomes [6,7].
YB-1 is involved in regulation of transcription [8,9] and translation
[10,11], alternative splicing [12,13], DNA reparation, gene-toxic
stress response, and development of multidrug resistance [14].
Depending on its amount, intracellular localization, and cell
context, YB-1 may act either as an antioncoprotein [15,16] or an
oncoprotein [17], stimulate the epithelial-mesenchymal transition
and metastasis [18], and serve as a marker of cancer cells and their
aggressiveness [19,20]. Recently, it was shown that YB-1 can be
secreted by a non-classical mechanism [21]. Extracellular YB-1
stimulates migration and proliferation of mesangial cells [21]
through activation of Notch-3 receptors [22]. For a comprehensive
review of YB-1 functions, see [23].
Mammalian YB-1 consists of a five-stranded b-barrel-structured
cold shock domain (CSD) [24] flanked by N- and C-terminal
domains. The N-terminal domain is known as an A/P-domain
because it is rich in alanine and proline, and the C-terminal
domain contains alternating clusters of positively and negatively
charged amino acid residues. The tertiary structure of the terminal
domains remains unknown and is believed to be disordered. As
shown previously, in solution and in protein-saturated complexes
with mRNA, YB-1 associates in multimers up to 800 Da [25,26].
Recently, we reported that YB-1 formed fibrils under high ionic
strength conditions, e. g., in the presence of 2 M LiCl. These fibrils
were 15 nm wide, had the shape of a helix with a period of 52 nm,
and their ends showed polarity. It was conjectured that YB-1 fibrils
were amyloids by nature [27].
Amyloids were discovered as protein deposits associated with
several neurodegenerative diseases including Alzheimer’s disease
[28]. They have elongated, unbranched fibril morphology, display
affinity for Congo red and Thioflavin T (ThT), and give a cross-b
X-ray diffraction pattern [29]. A number of proteins form in vitro
similar structures termed amyloid-like [28]. Later, several proteins
were reported to form functional structures with amyloid
properties [30]: for example, peptide hormones can be secreted
in the form of amyloids [31].
Here we describe (i) contribution of each domain of YB-1 to
fibril formation, (ii) the salt effect on formation of YB-1 fibrils and
the possibility of their appearance at physiological ionic strength,
and (iii) properties of the formed YB-1 fibrils. We found that fibril
formation by YB-1 is mediated by its CSD, while different regions
of its disordered terminal domains differentially contribute to the
process. We have shown that YB-1 fibrils are amyloid-like, but this
structure is reversible and disassembles under physiological
conditions.
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The cold shock domain of YB-1 is responsible for fibril
formation under high ionic strength conditions, whereas
its N- and C-terminal domains modulate this process
YB-1 consists of a conserved b-barrel-structured cold shock
domain flanked by N- and C-terminal domains that are predicted
to be intrinsically disordered, as shown by the disorder prediction
algorithm IsUnstruct [32] (Fig 1A). This prediction is supported by
the following two facts. First, 36 kDa YB-1 possesses an abnormal
mobility in SDS polyacrylamide gel electrophoresis that corre-
sponds to the mobility of a 50 kDa protein. Second, under
physiological conditions, YB-1 shows a circular dichroism
spectrum that is characteristic for an unfolded protein (see below).
Figure 1B shows the structural organization of YB-1 CSD as
follows from NMR [24]. The terminal domains are sketched.
Previously, we reported that YB-1 formed fibrils in the presence
of 2 M LiCl [27]. To find out which domain of YB-1 is responsible
for fibril formation, we used, apart from the full-length YB-1, its
three fragments: (i) YB-11–219 comprising the N-terminal domain,
CSD, and the first half of the C-terminal domain. Such a fragment
can appear in vivo under conditions of a DNA-damaging stress as a
result of YB-1 cleavage with 20 S proteasome [33]. It lacks the
cytoplasmic retention signal but preserves the nuclear localization
site. Therefore, it is mostly located in the nucleus; (ii) YB-11–129
comprising the N-terminal domain and CSD; (iii) YB-152–129
comprising solely CSD. YB-1 and its fragments are schematically
shown in Figure 1C. All these samples were incubated with 2 M
LiCl for 24 h. The absence of their degradation after incubation
was monitored by SDS gel electrophoresis (Fig 2). Then the
negatively stained samples were examined by transmission
electron microscopy (EM) and atomic force microscopy (AFM)
(Figs 3A–D). As found, the full length YB-1 formed fibrils of
various length that tended to associate in bundles (Fig 3A), which
was consistent with our previous data. The fragment YB-11–219
formed nothing but globular particles (Fig 3B) similar to those
described earlier for the full-length YB-1 [26]. YB-11–129 formed
short fibrils (Fig 3C) of the same morphology as those formed by
the full-length YB-1. YB-152–129 formed long fibrils, although in
less abundance (Fig 3D).
This allows concluding that CSD is responsible for YB-1 fibril
formation. The N-terminal domain presumably stimulates initia-
tion of this process, as follows from a higher number and a shorter
length of the fibrils formed by YB-11–129, as compared to YB-152–
129. As to the C-terminal domain, its first half prevents fibril
formation, while its last half neutralizes this negative effect.
Some YB-1 fragments may form fibrils at physiological
ionic strength
Next, we learned whether YB-1 and its fragments were capable
of forming fibrils at physiological ionic strength. The samples were
incubated in the presence of 0.15 M KCl and analyzed by EM
imaging (Fig 4). Under these conditions, the full-length YB-1 and
YB-11–219 gave merely globular particles (Figs 4A, B), while YB-
11–129 formed fibrils as abundantly as at high ionic strength
(Fig 4C). With 0.15 M KCl present, YB-152–129 gave a much lower
number of fibrils in comparison with that observed in the 2 M
LiCl conditions (cf. Fig 4D and Fig 3D). Its ability to form fibrils in
physiological conditions was seemingly exceeded by YB-11–129,a s
shown by microscopy that revealed only rather short sparse fibrils
(cf. Fig 4D and Fig 4C). Noteworthily, an increased concentration
of YB-152–129 and its incubation for 2 weeks gave elongated fibrils
capable of sheet forming (data not shown). Thus, YB-1 CSD can
form fibrils at physiological ionic strength as well, and this process
Figure 1. The domain organization of YB-1. (A), Prediction of structured and intrinsically disordered regions of YB-1 by IsUnstruct algorithm.
Disorder is assigned to score values greater than or equal to 0.5. CSD is highlighted by gray shading. (B), The tertiary structure of CSD and sketched
terminal domains. (C), YB-1 and its fragments used in the study. The indicated regions belong to different YB-1 domains.
doi:10.1371/journal.pone.0036969.g001
Figure 2. Electrophoretic analysis of YB-1 and its fragments
before and after incubation. YB-1 and its fragments before (2) and
after (+) 24 h incubation in 2 M LiCl were subjected to 13% SDS-PAGE in
a tris-tricine buffer system and stained with Coomassie brilliant blue.
Protein molecular weight markers are shown (lane M).
doi:10.1371/journal.pone.0036969.g002
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YB-1 fibrils exhibit amyloid-like properties
We presumed that YB-1 fibrils were amyloid-like. Originally,
amyloids were recognized by specific staining with Congo red. We
incubated concentrated YB-1 in the presence of 2 M LiCl until the
protein gel formed. Its staining with Congo red gave green
birefringence (Fig 5A) which strongly suggested the amyloid-like
nature of YB-1 fibrils.
The main characteristic feature of amyloids is occurrence of the
cross-b-structure. We incubated YB-1 under high ionic strength
conditions and analyzed changes occurring in its secondary
structure using circular dichroism spectrometry. To avoid
significant absorption in the far UV region by chloride ions, LiCl
was substituted by MgSO4. Under physiological conditions, YB-1
had a spectrum with the minimum near 200 nm, which is
characteristic for unfolded proteins. Incubation under high salt
conditions resulted in a spectrum with the minimum near 217 nm
characteristic for the b-structure (Fig 5B). To conclusively prove
the formation of the cross-b-structure, we prepared an oriented
YB-1 fiber sample and subjected it to X-ray diffraction analysis.
Two reflections at ,4.7 A ˚ and ,10.6 A ˚ were consistent with the
cross-b-sheet structure [34] (Fig 5C). Moreover, after incubation
with 0.2 M KCl, YB-11–129 showed the same Congo red staining
and X-ray diffraction pattern (data not shown) as those described
for YB-1 in 2 M LiCl.
Effect of different cations on formation of YB-1 amyloid-
like fibrils
To study the effect of different cations on formation of amyloid-
like fibrils by the full-length YB-1, we compared the effects of
different salts, namely, KCl, LiCl, MgCl2, and NaCl (containing
different cations and the same counterion Cl
2), on this process.
YB-1 samples were incubated at high concentration of different
metal chlorides, and amyloid formation was assessed from their
binding to a specific fluorescent dye Thioflavin T (Fig 6).
According to their ability to cause amyloid formation, the cations
were ordered Mg
2+.Li
+.Na
+$K
+.
Figure 3. Fibril formation by YB-1 and its fragments. Protein samples (10 mM) were incubated in the presence of 2 M LiCl for 24 h.
Supramolecular complex formation was visualized by EM (left) and AFM (right) imaging. (A), YB-1; (B), YB-11–219; (C), YB-11–129; (D), YB-152–129. Scale
bars are 0.4 mm where not indicated.
doi:10.1371/journal.pone.0036969.g003
Figure 4. Fibril formation by YB-1 and its fragments under physiological conditions. EM images of YB-1 (A), YB-11–219 (B), YB-11–129 (C), and
YB-152–129 (D) (10 mM) incubated in the presence of 0.15 M KCl for 92 h. Scale bars are 0.4 mm.
doi:10.1371/journal.pone.0036969.g004
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strength conditions
As a rule, the amyloid-like structures show high stability and
prove to be resistant even to dissociation with sodium dodecyl
sulfate [35].
It was of interest to learn whether YB-1 fibrils formed at high
ionic strength retained their stability at physiological salt
concentration. To do so, we grew fibrils in the presence of 2 M
KCl and then diluted the sample with water to a final KCl
concentration of 0.15 M. In control, YB-1 was incubated with
either 0.15 M KCl or 2 M KCl, and then the samples were diluted
with 0.15 M KCl or 2 M KCl, respectively, to adjust them to the
same protein concentration as in experiment. The presence of
amyloid-like aggregates was monitored by ThT fluorescence and
EM imaging (Fig 7). As seen from Figure 7A, ThT fluorescence
intensity of YB-1 incubated with 0.15 M KCl did not differ much
from that of ThT itself. In contrast, YB-1 incubation with 2 M
KCl resulted in a markedly increased ThT fluorescence, which
indicated the presence of amyloids. Surprisingly, the subsequent
decrease in KCl concentration down to 0.15 M reduced ThT
fluorescence of YB-1 incubated with 2 M KCl almost to the value
shown by the sample after its incubation with 0.15 M KCl. This
dramatic drop in ThT fluorescence indicated that YB-1 amyloid-
like fibrils had been disassembled.
An analysis of the same samples by EM imaging revealed a good
agreement with the ThT results. YB-1 incubation with 0.15 M
KCl gave no amyloids (Fig 7B, left), whereas its incubation with
2 M KCl resulted in distinct elongated fibrils (Fig 7B, middle). The
subsequent incubation of such fibrils with 0.15 M KCl made them
much shorter and less abundant (Fig 7B, right). A similar behavior
was demonstrated by YB-1 fibrils grown in 2 M LiCl after
substitution of 0.15 M KCl for 2 M LiCl by dialysis (Fig 7C).
Thus, amyloid-like fibrils formed by the full-length YB-1 at high
ionic strength are able to disintegrate under physiological ionic
strength conditions.
Discussion
We showed previously [27] that the full-length YB-1 forms
fibrils at a high concentration of LiCl (2 M), which brought the
Figure 5. YB-1 forms amyloid-like fibrils. (A), Congo red staining of YB-1 fibrils. YB-1 (,1.4 mM) was incubated under high ionic strength
conditions (2 M LiCl) for 72 h. Photographs were taken in a bright-field mode (left) or under cross-polarized light (right). (B), Circular dichroism
spectroscopy of YB-1. Spectra were obtained for 30 mM YB-1 in 0.15 M KCl (solid line) and after incubation with 1 M MgSO4 (dotted line). (C), X-ray
diffraction of an oriented YB-1 fibril sample.
doi:10.1371/journal.pone.0036969.g005
Figure 6. Effect of different salts on YB-1 fibril formation. YB-1
(10 mM) was incubated in 20 mM Hepes-KOH, pH 7.4, containing
different salts as indicated under the bars for 24 h at 20uC. Amyloid
formation was assessed by ThT fluorescence. Means and SD are shown
(n=3), and *or *** indicates t-test p,0.05 or p ,0.001, respectively.
doi:10.1371/journal.pone.0036969.g006
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the cell there are fibrillar structures vital for its living, like elements
of the cell skeleton that perform structural and transport functions.
A distinguishing feature of these structures is their dynamic nature.
Alongside with them, there are fibrillar structures termed amyloids
that complicate the organism’s life by provoking a number of
diseases. Amyloids are insoluble protein aggregates produced by
some soluble proteins. Their association may occur in vitro and
involve proteins of various structures. The association-favorable
conditions are usually other than physiological, and aggregation is
generally irreversible. Fibrillar aggregates formed in vitro have been
named amyloid-like structures [28,36]. The characteristics of
amyloids and amyloid-like structures are their affinity for Congo
red with resulting green birefringence and an X-ray diffraction
pattern typical for the cross-b-structure [37].
Previously, the general morphology of YB-1 fibrils, as shown by
microscopy, allowed their preliminary assignment to amyloid-like
fibrils [27]. In this study we have demonstrated that YB-1 fibrils
show the following amyloid properties: (i) ability to be stained with
Congo red and Thioflavin T, (ii) an elevated level of the b-
structure (as shown by CD spectroscopy), and (iii) a characteristic
pattern of X-ray diffraction. However, unlike most of known
amyloid-like structures that associate either at extreme pH values
or at elevated temperature, YB-1 fibrils are formed at physiological
pH values and 20–37uC. The basic prerequisite to YB-1 fibril
growth is a high salt concentration. Besides, YB-1 fibrils appear to
be reversible and easily disintegrating under conditions of
physiological salt concentration. These peculiarities make YB-1
fibrils an interesting subject for further studies.
The stimulating effect of a high salt concentration on formation
of amyloid fibrils may occur due to three principal factors: (i)
Debye-Hu ¨ckel screening, (ii) specific ion-peptide interactions, and
(iii) changes in the water structure. Generally, Debye-Hu ¨ckel
screening is not considered to be a possible stimulating mechanism
of amyloid aggregation [38–40]. As reported [40], formation of b2-
microglobulin fibrils is mostly stimulated by the mechanism of
specific ion-peptide interactions. Yet, as seen from their effect on
a-synuclein amyloid aggregation, the ions are ordered as the
Hofmeister series, which points to importance of changes in the
general water structure [39]. In case of Ab(1–40) peptide fibrils,
the both mechanisms are presumably involved [38]. According to
their ability to cause YB-1 amyloid formation, the cations are
ordered Mg
2+.Li
+.Na
+$K
+, which coincides with their order
for the Ab(1–40) peptide [38]. It may be believed that the salt ions
play a role in YB-1 fibril formation due to both their specific
interactions with charged groups of the protein and changes in the
water structure.
To identify the YB-1 site responsible for fibril formation, we
checked the ability of the studied YB-1 fragments to form fibrils in
2 M LiCl. Similar to the full-length YB-1, this ability was shown
by YB-11–129 and YB-152–129, but not by the largest fragment YB-
11–219. These results suggest that YB-1 forms fibrils using its CSD,
while the first half of the C-terminal domain inhibits the process,
and the last half neutralizes this negative effect. The N-terminal
domain presumably stimulates initiation of fibril formation,
because in its absence YB-152–129 forms a small number of long
fibrils, while in its presence the full-length YB-1 and YB-11–129
form many fibrils of various lengths.
Atphysiological ionicstrengththe full-lengthYB-1and YB-11–219
are unable to form fibrils, while the isolated CSD (YB-152–129)
preservesthisability, thoughthefibrilsareformedinlessabundance
than at high ionic strength. Importantly, the presence of the N-
terminal domain enhances the fibril-forming activity of CSD. The
first half of the C-terminal domain behaves likewise at both
physiological and high ionic strength, i.e., prevents fibril formation,
but its last half is ionic strength-dependent: at high ionic strength
it neutralizes the inhibiting effect of the first part, while in
physiological conditions it does not.
Thus, we have shown that CSD plays the key role in formation
of YB-1 amyloid-like fibrils, while the N- and C-terminal domains
positively or negatively modulate this process.
To date, many models of amyloid formation have been proposed
[29]. Itis believedthat thisprocess ismediated byproteinmolecules
in a partially unfolded state. Interestingly, the isolated CSD in
solution has low stability, and a high percentage of CSD molecules
areintheunfoldedstate[24].TheYB-1CSD-mediatedmechanism
Figure 7. Disassembly of YB-1 amyloid-like fibrils at physiological ionic strength. (A) and (B), YB-1 (56.8 mM) was incubated with 0.15 M or
2 M KCl for 24 h. An aliquot of YB-1 pre-incubated with 2 M KCl was diluted to 0.15 M KCl. Remaining samples were diluted to the same final protein
concentration (4.26 mM) with appropriate KCl solutions to keep the salt concentration unchanged. The samples were incubated for 1 h at room
temperature and analyzed by (A), ThT fluorescence (means and SD are shown (n=3), and *** indicates t-test p,0.001) and (B), EM imaging. (C), YB-1
(30 mM) was incubated with 0.15 M KCl or 2 M LiCl for 24 h. An aliquot of YB-1 pre-incubated with 2 M LiCl was dialyzed against 0.15 M KCl. Fibril
formation was visualized by AFM imaging. Scale bars are 0.4 mm. Ionic strength conditions during the incubation are indicated.
doi:10.1371/journal.pone.0036969.g007
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of fibril formation by the major cold shock protein Ec-CspA from
Escherichiacoli.ThesequenceidentityofthisbacterialproteintoYB-1
CSD is 47%, and it has a b-barrel spatial structure as well. It was
shown that Ec-CspA forms amyloid-like fibrils at low pH. As
demonstrated by NMR, in these conditions its b-barrel structure is
partially unfolded but still preserves some features of the native
structure formed by the strands b1b2b3. This suggests that the
amyloid cross-b-structure results from intermolecular parallel
pairing of the strands b1 and b3 [41].
Another bacterial cold shock protein Bc-Csp from Bacillus
caldolyticus forms domain-swapped dimers when crystallized in
complex with hexathymidine [42]. This mechanism may underlie
amyloid formation as well, as has been demonstrated for the b-
structured protein cystatin C [43]. It cannot be ruled out that the
domain swapping mechanism [29,44] is also used in formation of
amyloid-like structures by CSD-containing proteins, including YB-
1.
In this study we have shown that the evolutionally added N- and
C-terminal domains of YB-1 can significantly influence the CSD
ability to form fibrils. It follows from the above results that the
charged residue-rich C-terminal domain includes sites producing
differentialeffectsonfibrilformation.Itwaspreviouslyreportedthat
at physiological ionic strength YB-1 can form multimers through its
C-terminal domain [25,45] that acts like a charged zipper [46].
Another supposition was that in the full-length YB-1 the last half of
its C-terminal domain interacts with the first half to give a hairpin-
loop structure [33], where the majority of charged residues are
presumably involved in interactions with one another, while only
few interact with CSD. A high ionic strength possibly prevents this
interaction, thereby depriving the C-terminal domain of any
influence on the process of fibril formation in these conditions.
That is why the full-length YB-1 and YB-11–129 lacking this domain
form fibrils with equal efficiency at 2 M LiCl. Then, the absence of
YB-1 fibrils at 0.15 M KCl ionic strength may be explained by
additionalinteractionsoccurringbetweenthehairpin-loopstructure
and CSD which stabilize the CSD structure and prevent CSD-
mediated fibril formation by the full-length YB-1.
With the absent last half of the C-terminal domain, YB-11–219
forms no hairpin-loop structure, and unbound charged residues of
the first half can interact with CSD at both low and high ionic
strength, thereby preventing CSD-mediated fibril formation. This
model is supported by the fact that no fibril formed by YB-11–219
was observed either at low or high ionic strength. With the
completely cut off C-terminal domain, stability of CSD in YB-11–
129 appears unsupported, and then the CSD-mediated fibril
formation becomes independent of ionic conditions. The removal
of the N-terminal domain from YB-11–129 makes the fibril-forming
ability of the remaining CSD (YB-152–129) much lower at
physiological ionic strength. Presumably, the N-terminal domain
either promotes CSD transition to a conformation optimal for
fibril forming or stabilizes the formed amyloids.
Amyloids have long been considered to be insoluble protein
aggregates that can accumulate in an organism and provoke
various disfunctions. High stability was believed to be one of their
basic features manifested as their resistance against proteolysis
with proteinase K [47] or dissociation with sodium dodecyl sulfate
[35]. Later, it was found that amyloids could play a physiological
role in various organisms, specifically in mammals. For example,
an amyloid derived from the protein Pmel17 showed template
activity and accelerated covalent polymerization of reactive
molecules into melanin [48]. Interestingly, the repeat domain of
Pmel17 formed amyloids under mildly acidic conditions, while
under neutral conditions these amyloids dissolved [49]. Moreover,
peptide and protein hormones in secretory granules of the
endocrine system can be stored in an amyloid-like cross-b-sheet-
rich conformation. Upon signaling, secretory granules are
secreted, and the cross-b-sheet structure of the amyloid enables
a controlled release of monomeric, functional hormone [31].
Among the studied conditions, only high ionic strength allows
efficient fibril formation by the full-length YB-1. However, it
cannot be ruled out that the complex intracellular environment
can produce conditions favorable for formation of amyloid-like
structures by YB-1, e.g., in the course of its post-translational
modifications or its interactions with ligands. It is known that YB-1
is phosphorylated by some kinases and binds not only to DNA and
mRNA but also to many proteins. The literature describes the
effect of ligands on fibril formation. For example, some peptide
hormones form amyloid structures exclusively in the presence of
glycosaminoglycans [31].
When in complex with ligands, YB-1 can be a component of
various intracellular organelles, like stress granules [4] and
processing bodies [5], secretory granules [21], centrosomes [6,7]
and nucleoli [50]; in the nucleoplasm YB-1 can show speckled
distribution and be a member of so far unidentified structures and
complexes [51]; it can interact with microfilaments [3] and
microtubules [2,6] and contribute to formation of the latter [2].
Within these structures YB-1 presumably could realize its ability to
form reversible amyloids which might be localized in secretory
granules during YB-1 secretion from the cell and then be released
into the intercellular space in the way described for peptide
hormones [31]. Noteworthily, the macrophage migration inhibi-
tory factor secreted like YB-1 by a non-classical mechanism [52]
can form amyloid-like fibrils. But these are effectively formed at
pH ,4, and their ability to dissociate in physiological conditions
has not been assayed [53].
Apart from the above, the amyloid-like conformation can serve
for YB-1 storing in the cell.
It may be expected that in the cell fibrils can be formed by YB-1
fragments. As shown in the current study, fibril formation is
effectively performed by some YB-1 fragments in physiological
conditions. These fragments are sometimes involved in secretion.
For example, a YB-1 fragment with an electrophoretic mobility of
about 18 kDa (YB-1/p18) has been recently detected in human
blood[54]. Thisfragment containedCSDbutlacked someportions
of the N- and C-terminal sequences. Since YB-1/p18 was often
detected in plasma of patients with advanced cancerous diseases, it
wasproposedfortheuseasacancermarker[54].Itshouldbenoted
that electrophoretic mobility of YB-1/p18 is characteristic for the
fragmentYB-11–129thatcontainsCSD(Fig3)andisable,according
to this study, to form fibrils at physiological ionic strength. In
contrast, other YB-1 fragments, e.g., YB-11–219 detected in the cell
nucleus, cannot form amyloid-like structures in any of the studied
conditions, which may also be physiologically relevant.
Materials and Methods
Protein purification and fibrillogenesis
The full-length YB-1 was purified as described earlier [27,55].
Briefly, YB-1 was synthesized in E. coli from plasmid pET-3-1-YB-
1 and purified by Heparine-Sepharose, MonoS and Superose 12
(GE Healthcare, Sweden) chromatography. Fractions containing
pure YB-1 were concentrated and dialyzed against 20 mM Hepes-
KOH, 0.5 M KCl, pH 7.4. Plasmid pET-3-1-YB-11–219 was
provided by Dr. Alexey Sorokin. YB-11–219 was purified in the
same way as YB-1 except that dialyzed against 20 mM Hepes-
KOH, 0.15 M KCl, pH 7.4. To construct plasmids for YB-11–129
and YB-152–129, the corresponding DNA fragments were PCR-
YB-1 Forms Amyloid-Like Fibrils
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YB-152–129 were expressed in E. coli and isolated by ammonium
sulfate fractionation and chromatography using SP-Sepharose,
Phenyl-Sepharose and MonoS columns (GE Healthcare). YB-11–
129 and YB-152–129 were stored in 20 mM Hepes-KOH, 0.2 M
KCl, pH 7.4 or 50 mM potassium phosphate, pH 7.4, respec-
tively. Concentrations were estimated from 280 nm absorbance
using calculated extinction coefficients (ProtParam tool, http://
expasy.org/tools/protparam.html). The OD280/OD260 ratios
were ,2, thus showing the absence of nucleic acids from the
protein samples. To test fibril forming capability, the protein
samples (10 mM) were incubated in 20 mM Hepes-KOH, pH 7.4,
containing 0.15 M KCl for 92 h or 2 M LiCl for 24 h at 20uC and
analyzed by EM and AFM.
Congo red staining
Congo red staining was performed as described [37] with minor
modifications. YB-1 (,1.4 mM or ,50 mg/ml) was incubated
with 2 M LiCl at 20uC. The protein formed gel after 72 h
incubation. An aliquot of YB-1 gel was transferred to deionized
water (1 ml) for 1 min to wash out the salt, centrifuged at
12,000 rpm and applied onto a glass slide. The air-dried protein
spot was stained with 0.1% Congo red in water and photographed
using a microscope equipped with two polarizers.
X-ray diffraction study
An oriented YB-1 fiber sample was prepared using the
simplified stretch frame method [56]. The protein gel sample
was washed with water as described under Congo red staining
and placed between waxed ends of glass capillaries mounted in a
petri dish. The rod-like air-dried sample was placed under an X-
ray beam. The fiber diffraction images were collected using a
Microstar X-ray generator with HELIOX optics equipped with a
Platinum
135 CCD detector (X8 Proteum system, Bruker AXS). Cu
Ka radiation (l=1.54A ˚) was used. The samples were oriented
perpendicular to the X-ray beam using a 4-axis kappa goniometer.
Transmission EM
Protein samples were diluted to 3 mM of protein, adsorbed onto
copper grids coated with 0.2% formvar in chloroform for 2 min,
briefly washed with water, stained with 1% uranyl acetate or 2%
ammoniummolybdate(aqueoussolutions)for1 min,andexamined
using a JEM-100C microscope (JEOL, Japan) operating at 80 kV.
AFM imaging
For AFM studies, the protein sample was diluted to 3 mM, and
immediately a 5 ml aliquot was applied onto freshly cleaved mica
and left for 15 min in a humid chamber. The substrate-deposited
sample was washed twice with water and air dried. The AFM
analysis was made using a scanning probe microscope NTEGRA
VITA (NT-MDT Company, Zelenograd, Russia) with a standard
NSG 03 (NT-MDT) silicon cantilever. The resonance frequency
of the cantilever was 62–123 kHz, and its length was 100 mm. Tips
with an apex curvature radius of 10 nm were used. The samples
were probed in a semi-contact mode in air.
Fibril dissociation
YB-1 (56.8 mM) was incubated with 0.15 M or 2 M KCl and
0.1 M potassium phosphate, pH 7.4, for 24 h at 37uC. An aliquot
of YB-1 preincubated with 2 M KCl was diluted with water to
final concentrations of 0.15 M KCl and 4.26 mM YB-1. The
remaining samples were diluted to the same final protein
concentration (4.26 mM) with appropriate KCl solutions to keep
the salt concentration unchanged. The resulting samples were
incubated for 1 h at room temperature, tested for ThT binding
and imaged by EM. Alternatively, YB-1 was incubated with
0.15 M or 2 M LiCl and 20 mM Hepes-KOH, pH 7.4, for 24 h
at 20uC. An aliquot of YB-1 preincubated with 2 M LiCl was
dialyzed against 20 mM Hepes-KOH, 0.15 M KCl, pH 7.4. The
resulting samples were imaged by AFM.
ThT fluorescence
ThT fluorescence was analysed as described [37] with minor
modifications. ThT 506stock solution was added to a protein
sample to a final ThT concentration of 50 mM. Fluorescence data
were obtained using a Cary Eclipse fluorescence spectrophotom-
eter (Varian, U.S.A.) with a 3 mm quartz cell with excitation and
emission wavelengths of 440 nm and 482 nm, respectively.
Circular dichroism spectroscopy
CD spectra were recorded using a JASCO J-810 CD
spectropolarimeter (JASCO, Japan) equipped with a nitrogen-
swept cell of 1 mm optical path. Samples containing 30 mM YB-1
in 20 mM Tris-HCl, pH 7.4, supplemented with either 0.15 M
KCl or 1 M MgSO4 were analyzed. The sample with 0.15 M KCl
was freshly prepared, while the sample with 1 M MgSO4 was
incubated for 92 h at 20uC prior to analysis. Each spectrum was
corrected for contributions from buffer solutions.
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